港股开盘 | 恒指低开0.32% 医药股活跃 百济神州(06160)涨近3%
智通财经网·2025-12-16 01:41

Group 1 - The Hang Seng Index opened down 0.32%, while the Hang Seng Tech Index fell by 0.56%. Pharmaceutical stocks were active, with BeiGene rising nearly 3%, while tech stocks experienced the largest declines [1] Group 2 - Guotai Junan Securities believes that the short-term adjustment of the Hong Kong stock market will open up space for a rise in 2026. In November, southbound funds net inflow into the Hong Kong stock market exceeded 110 billion RMB. This reflects the ample liquidity of mainland funds and their strong willingness to position in Hong Kong stocks at low levels [2] - CITIC Securities predicts that in 2026, the Hong Kong stock market will benefit from internal "14th Five-Year Plan" catalysts and external major economies' "fiscal + monetary" easing. With macroeconomic improvement, the performance of Hong Kong stocks is expected to transition from "earnings recovery" to "revenue expansion," creating a sustainable trend of revenue and profit resonance [2] - Dongwu Securities anticipates that the Hong Kong stock market will continue to rebound next year for several reasons: expected continued interest rate cuts by the Federal Reserve in 2026, a phase of easing in China-U.S. relations, synchronized deepening of domestic monetary and fiscal policies, further improvement in corporate earnings, sustained inflow of southbound funds due to "profit-making effects," and potential additional contributions from overseas funds [2]